Prenetics Global Limited
PRE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.05 | 0.01 | 0.04 | -0.00 |
| FCF Yield | -40.63% | -22.08% | 5.37% | 0.47% |
| EV / EBITDA | -0.53 | -0.48 | -0.06 | -4.22 |
| Quality | ||||
| ROIC | -23.12% | -23.90% | -25.58% | -61.97% |
| Gross Margin | 50.29% | 40.61% | 27.48% | 28.75% |
| Cash Conversion Ratio | 0.58 | 0.21 | -0.08 | -0.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 32.50% | 20.16% | -41.33% | 2,322,719.11% |
| Free Cash Flow Growth | -103.99% | -279.60% | 307.73% | 133.74% |
| Safety | ||||
| Net Debt / EBITDA | 0.90 | 0.90 | 0.64 | -2.18 |
| Interest Coverage | -237.16 | -433.78 | -272.82 | -1,341.78 |
| Efficiency | ||||
| Inventory Turnover | 2.32 | 4.13 | 2.11 | 1.31 |
| Cash Conversion Cycle | 136.31 | 130.03 | 1,072.87 | 1,241.52 |